0000950103-15-008201.txt : 20151016 0000950103-15-008201.hdr.sgml : 20151016 20151016085852 ACCESSION NUMBER: 0000950103-15-008201 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20151013 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151016 DATE AS OF CHANGE: 20151016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 151161158 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: RG24 8EP BUSINESS PHONE: 441256894000 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: RG24 8EP FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp60537_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 13, 2015

 

Shire plc

 

 

(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands

 

 

(State or other jurisdiction of incorporation)

 

0-29630 98-0601486
(Commission File Number) (IRS Employer Identification No.)

 

5 Riverwalk, Citywest Business Campus, Dublin

24, Republic of Ireland

 

 

(Address of principal executive offices) (Zip code)
   
Registrant's telephone number, including area code +353 1 429 7700

 

(Address of principal executive offices) (Zip code)

 

Registrant's telephone number, including area code +353 1 429 7700

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))

 

 

 

 

Item 8.01.Other Events

 

Shire plc have issued the press release attached hereto as Exhibit 99.1 which is incorporated by reference herein.

 

Item 9.01.Financial Statements and Exhibits

 

(d) Exhibits. The following exhibit is filed herewith:

 

99.1Press Release dated October 13, 2015

 

2 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SHIRE PLC  
     
     
  By:    /s/ B Mordan  
    Name:       Bill Mordan  
    Title: Company Secretary  

 

Dated: October 16, 2015

 

3 

 

EXHIBIT INDEX

 

Number

Description

   
99.1 Press Release dated  October 13, 2015

 

 

 

EX-99.1 2 dp60537_ex9901.htm EXHIBIT 99.1

Exhibit 99.1

 

Press Release  
www.shire.com  

 

 

 

Shire to announce third quarter 2015 results

 

Dublin, Ireland – October 13, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2015 earnings on Friday October 23, 2015.

 

Results press release will be issued at: 12:00 BST / 07:00 EDT
   
Investor conference call time: 14:00 BST / 09:00 EDT

 

 

Live conference call for investors:

Flemming Ornskov, Chief Executive Officer and Jeff Poulton, Chief Financial Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.

 

The details of the conference call are as follows:

 

UK dial in: 0808 237 0030 or 020 3139 4830
US dial in: 1 866 928 7517 or 1 718 873 9077
International Access Numbers: Click here
Password/Conf ID: 25841912#
Live Webcast: Click here

 

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for three months. Details can be found on our Investor Relations website http://investors.shire.com/.

 

For further information please contact:

 

Investor Relations    
     
Matthew Osborne mattosborne@shire.com +1 781 482 9502
     
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157

 

Notes to editors

 

Shire enables people with life-altering conditions to lead better lives.

 

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

 

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

 

www.shire.com

 

 

 

 

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

 

GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg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end